New breast cancer drugs

Due to people's current carelessness in living habits and diet, the incidence of cancer is becoming higher and higher. Current medical technology does not have a cure for cancer and can only inhibit the growth of cancer cells through chemotherapy. There are many anti-cancer drugs that can also inhibit cell division. Among all cancer patients, breast cancer patients are the most numerous. So what are the new drugs for treating breast cancer?

The occurrence of diseases is inseparable from people’s daily living habits and eating habits. In recent years, due to people’s irregular eating habits and changes in living habits, many diseases have continued to attack, seriously threatening people’s health. Breast cancer is a very common disease among them. This disease is a malignant tumor disease with a high incidence and mortality rate. Therefore, timely control of the disease is very necessary for breast cancer. Among them, chemotherapy is an important means of treating breast cancer. This method has a direct inhibitory effect on cancer. The following are the drugs commonly used in breast cancer chemotherapy.

1. Xeloda (capecitabine tablets)

For the treatment of advanced primary or recurrent metastatic breast cancer and rectal cancer, colon cancer, Roche's targeted chemoradiotherapy Chinese medicine "Xeloda" has been approved by the State Food and Drug Administration for the treatment of clinically advanced gastric cancer. It has a reliable comprehensive clinical diagnostic efficacy and is easy to take. It is recognized by the majority of cancer patients and is worthy of application and promotion.

2. Furui (letrozole tablets)

By inhibiting aromatase, the estrogen level is reduced, thereby eliminating the stimulating effect of estrogen on tumor growth. Various preclinical clinical studies have shown that letrozole has no potential toxicity to systemic systems and target organs, and has special symptoms of good tolerance and strong pharmacological effects. Compared with other aromatase inhibitors and anti-estrogen Chinese medicines, letrozole has a stronger anti-tumor effect and is mainly used in the treatment of postmenopausal patients with advanced breast cancer who are receiving anti-estrogen therapy.

3. Sulai (exemestane tablets)

It is an endocrine therapy drug whose mechanism of action is mainly to inhibit the production of estrogen by inhibiting aromatase. It is mainly suitable for postmenopausal patients with advanced breast cancer whose disease progresses clinically after treatment with tamoxifen.